Background: Potassium bromate (KBrO 3 ), used in both the food and cosmetics industry, and a drinking water disinfection by-product, is a nephrotoxic compound and rodent carcinogen. To gain insight into the carcinogenic mechanism of action and provide possible biomarkers of KBrO 3 exposure, the gene expression in kidneys from chronically exposed male F344 rats was investigated.
Background
The disinfection of public drinking water over the past century has dramatically decreased infectious waterborne diseases and is a hallmark of American public health policy. The benefi ts of drinking water disinfection are well recognized, however, an undesirable side effect is the production of disinfection by-products (DBPs). These DBPs are formed when disinfectants such as chlorine, chloramine, and ozone react with organic and inorganic matter in water. In the mid 1970's, it was discovered that trihalomethanes (THMs) were produced in chlorination of drinking water and that they are carcinogenic in laboratory animals (Rook, 1974; Bellar et al. 1974; NCI, 1976) . Because of the potential health risks associated with THMs, in 1979 the U.S. Environmental Protection Agency (U.S. EPA) began the regulation of DBPs in the water supply. Initially, concern focused on the trihalomethanes (THMs), but it is now recognized that a wide variety of DBPs are produced during chlorination.
In an effort to reduce exposure to halogenated DBPs, many utilities have switched to ozonation as an alternative treatment method to chlorination. Ozonation is also preferred because it reduces the turbidity of the water and is effective in treating chlorine resistant organisms. However, if ozonation is performed using surface water high in bromide content, brominated by-products, such as bromate ion (BrO 3 -), can be generated (Fiessinger et al. 1985) . Potassium bromate (KBrO 3 ), a salt of the bromate ion, is nephro-and neurotoxic in humans and carcinogenic in rodents (IARC, 1986; Kurokawa et al. 1990 ). Under the current guidelines for cancer risk assessment (U.S. EPA, 1986) , bromate is classifi ed as a probable human carcinogen due to its kidney carcinogenicity in male and female rats following exposure in drinking water (Kurokawa et al. 1983 (Kurokawa et al. , 1986a (Kurokawa et al. , 1986b DeAngelo et al. 1998; Wolf et al. 1998) . A dose-response relationship in rat kidneys was observed in progressive severity from renal dysplastic foci, preneoplastic lesions, through renal adenomas, and fi nally renal carcinoma (Kurokawa et al. 1986a; DeAngelo et al. 1998; Wolf et al. 1998) .
Mechanistic studies by Umemura et al. (2004 Umemura et al. ( , 2006 demonstrated dose-dependent changes in oxidative stress and cell proliferation parameters at carcinogenic doses of potassium bromate in male and female rat kidneys. After four weeks of continuous drinking water exposure, 8-oxodeoxyguanosine levels (8-oxodG), an indicator of promutagenic oxidative DNA damage (Wood et al. 1990; Shibutani et al. 1991) , were signifi cantly elevated in male and female rats administered potassium bromate at concentrations of 250 ppm and higher. In addition, BrdU labeling, an indicator of cell proliferation, was also increased in the proximal tubule of female rats at similar concentrations and in male rats at concentrations as low as 30 ppm. It was suggested, however, that the susceptibility of the male rat to increased cell proliferation at lower concentrations was probably attributable to increased α2u-globulin in the male rat proximal tubule. These studies provide important information regarding the potential mechanism of action of potassium bromate carcinogenicity.
The primary objective in this study was to examine renal gene expression differences in male F344 rats exposed to a non-carcinogenic and carcinogenic dose (20 and 400 ppm, respectively) of KBrO 3 in drinking water for 52 wk. Furthermore, renal gene expression from the high dose (400 ppm) and adenomas from 100 wk exposed animals were examined and compared to the 52 wk exposure groups. This was accomplished by extracting kidney and adenoma RNA from rats exposed in the previous 1998 DeAngelo et al. study. Comparisons of gene expression profi les between these groups were used to identify functional pathways and individual genes that might contribute to the carcinogenic mechanism of action for KBrO 3 and provide insight into potential biomarkers of exposure.
Methods

Animal maintenance
Complete study details were published previously . Briefl y, KBrO 3 (99%; CAS 7758-01-2) dissolved in deionized water at concentrations of 0, 20, 100, 200, and 400 ppm was administered to male F344 rats as the sole water source for 12, 26, 52, 78, or 100 wk. Rats, 28 to 30-days-old, were allowed to acclimate for 1 wk and then randomly assigned to treatment groups. Treatment rooms were maintained at 20-22ºC and 40-60% humidity with a 12-hr light: dark cycle. Rats were housed 3 per cage on wood chips and provided Purina Rodent Laboratory Chow (St. Louis, MO) and water ad libitum. Animals were observed daily and moribund animals were euthanized and necropsied. Six animals from each group were euthanized by CO 2 asphyxiation and necropsied after 52 wk of treatment. At necropsy, kidneys were removed, washed, fl ash frozen in liquid nitrogen, and stored at -80ºC.
Microarray experiment
For the microarray experiment, rats exposed to 0, 20, and 400 ppm KBrO 3 for 52 wk, were selected because they represent a control, non-carcinogenic, and carcinogenic dose, respectively Wolf et al. 1998) . Kidneys from animals exposed to 20 and 400 ppm KBrO 3 for 52 wk were compared to kidneys from 52 wk control animals. In addition, kidneys from rats exposed to 0 and 400 ppm KBrO 3 and two adenomas from animals exposed for 100 wk were also examined. For this comparison, kidneys from the 100 wk high dose and adenomas were compared to kidneys from 100 wk control animals. Kidney RNA was extracted from three animals per dose group in the 52 wk exposure, and two animals per dose group in the 100 wk samples. RNA from two 100 wk adenomas were also extracted. RNA extraction was performed by acid guanidinium isothiocynate-phenol-bromochloropropane treatment (Tri reagent; Molecular Research Center, Inc., Cincinnati, OH, U.S.A.) and purifi ed on an affi nity resin (RNeasy; Qiagen, Valencia, CA) according to manufacturer instructions. Extractions were tested on an Agilent Bioanalyzer to determine RNA quality. Clearly defi ned 28S and 18S bands were observed on all samples used for microarray analysis. Samples showing degradation were not used for microarray analysis. Microarray procedures were performed as recommended by the manufacturer of the GeneChip system (Affymetrix, Inc, Santa Clara, CA, U.S.A.). The gene expression probe array used was the Rat Expression Array 230A gene chip containing 15,866 probe sets. For each animal, one kidney sample was used for gene expression analysis. Chips were examined by M versus A plots, chip clustering, and principal component analysis to determine outlying chips. Arrays demonstrating poor hybridization were not used for analysis.
Data analysis
The resulting image fi les (.cel) were normalized using the procedure of Li and Wong [D-chip] (2001a; 2001b) and the determination of signifi cant differences between groups were performed by using the web interface of Cyber-T [http://visitor. ics.uci.edu/genex/cybert/] (Baldi and Long, 2001) . A tutorial for using both D-chip and Cyber-T, found on the Cyber-T website, was used as the procedure for this analysis. Multiple testing correction and false discovery rate test were conducted by using the method of Benjamini and Hochberg (1995) on P-values: P = < (i/m)q, where i = # of genes accepted at selected p, m = total # genes, and q = desired false discovery rate. Determination of false positives was performed by: fp = (Pbh * total # genes). This resulted in a unique P-value for each comparison. Genes expressed at levels different than control such that a corrected P-value less than 0.05 were classifi ed as differentially expressed genes (DEG) and annotated using NetAffx (http:// www.affymetrix.com). Individual literature review on each DEG was conducted and used to classify genes into functional groups.
Kidney developmental gene response in KBrO 3 induced adenoma
Gene expression analysis has become suffi ciently standardized that comparisons between experimental datasets can yield insights into biological processes such as the differentiation of renal cells. In this vein, we compared our dataset of gene expression in whole adult rat kidney to that collected and analyzed by Stuart et al. (2001) . This study performed the fi rst high density oligonucleotide microarray investigation of kidney development using the 8,740 gene Affymetrix rat U34A microarray. Multiple developmental stages were examined, including embryonic day 13 (E13), E15, E17, E19, newborn, 1 wk, and adult. Cluster analysis defi ned fi ve temporal expression groups. Early group consisted of genes with very high expression in the early embryonic kidney, many with roles in protein translation and DNA replication. Prenatal group consisted of genes that peaked in mid-embryogenesis and contained many transcripts specifying proteins of the extracellular matrix. Neonatal group consisted of transcripts that peaked in the neonatal period and contained a number of retrotransposon RNAs. Steady group contained genes that steadily increased in relative expression levels throughout development, including many genes involved in energy metabolism and ion and water transport. Adult group consisted of genes with relatively low levels of expression throughout embryogenesis but with markedly higher levels in the adult kidney; this group included a heterogeneous mix of transporters, detoxifi cation enzymes, and oxidative stress genes.
Lists of the fi ve groups of genes identifi ed in Stuart et al. (2001) , were obtained from the supplemental data website (http://organogenesis. ucsd.edu/). These gene-lists used U34A probe set identifi ers. We determined the Rat Expression Array 230A probe set identifi ers that corresponded to the U34A probe sets using the best match comparison fi le from Affymetrix. For the fi ve kidney development groups mentioned above, there were 838, 168, 61, 510, and 193 genes located on the U34 array and 676, 126, 42, 428, and 155 genes located on the Rat Expression Array 230A array. The minimum sequence identity for a given probe set between the U34A and Rat Expression Array 230A array was 93% and the average identity was greater than 99%. For each group, the genes that were identifi ed in the Affymetrix best match comparison file constituted the gene members for that group in subsequent analysis.
Real time PCR determination of gene expression
Quantitative real-time rtPCR (QRT-rtPCR) data was collected from fresh aliquots of the total RNA samples used to obtain array data. On average, 85 ng of total RNA was loaded in a one-step QRTrtPCR reaction. Multiscribe reverse transcriptase was used to generate the cDNA template followed by amplifi cation with AmpliTaq Gold DNA polymerase (Applied Biosystems). Target specific assays were either custom designed or purchased from Applied Biosystems' TaqMan Assays on Demand. All reactions were performed according to manufacturer's procedures. The QRT-rtPCR cycling parameters were: 48ºC, 45 min cDNA synthesis; 95ºC, 10 min AmpliTaq Gold (Applied Biosystems) activation; and 40 cycles of amplifi cation at 94ºC, 15 sec melting followed by 60ºC, 1 min annealing/extension. Reaction volumes totaled 20 μl and were run in triplicate in 384 well plates on an ABI prism 7900HT. Based on the array data, Rpl27 (ribosomal protein L27) was chosen as a reference gene since it exhibited no differential gene expression across treatment groups and showed similar expression levels to the genes of interest. Confi rmation that Rpl27 was not differentially expressed across treatment groups was confirmed by QRT-rtPCR analysis (data not shown).
Results
Microarray analysis
The results of the statistical comparison among tissues from the 52 wk control, low, and high dose groups, and the 100 wk control, high, and adenoma groups are given in Table 1 . This study has been archived in ArrayExpress under accession number E-TOXM-21.
Analysis of gene expression
Gene ontology (GO) analysis of DEG expression in the kidney from male F344 rats exposed to low (20 ppm) and high (400 ppm) KBrO 3 for 52 wk are shown in Table 2 . The individual functional group information composed of gene symbol and name, Affymetrix and accession numbers, and fold change are given for oxidative stress (Table 3) , and kidney function / ion transport (Table 4) genes. In addition to the above mentioned groups, a large amount of lipid metabolism, oxidoreductase, and cellular function genes were observed and are shown as additional fi les: "lipid metabolism table. pdf, oxidoreductase table.pdf and cellular function table.pdf. " A total of 99 and 139 genes were used to provide an interpretive basis for differences in Table 1 . Results of the statistical comparison between 52 wk low, 52 wk high, 100 wk high, and 100 wk adenoma and their corresponding control. Shown are the numbers of genes less than 0.01 that contribute to the p-value calculation as given in the methods. The resultant p-value and the number of false positives are shown, as well as the number of differentially expressed and annotated genes. The gene expression probe array used was the Affymetrix Rat Expression Array 230A gene chip containing 15,866 probe sets. expression that were observed in the kidneys of rats treated with non-carcinogenic and carcinogenic doses, respectively. Analysis of the low dose showed a general suppression of gene expression with 71% of genes down-regulated relative to control tissues compared to 56% in the high dose. The most notable down-regulated groups in the low dose were oxidative stress and kidney function with 100% and 77% down-regulated, respectively. In the high dose, 87% of genes in kidney function and 90% of genes in lipid metabolism groups were down-regulated. Overall these changes suggest a general suppression of gene expression in the low dose group, especially those genes involved in oxidative stress and kidney function. This is in contrast to the high dose, where kidney function and lipid metabolism genes are suppressed in concert with an increased amount of oxidative stress related genes.
Genes
A comparison of genes whose expression was signifi cantly altered in the 52 wk high dose (400 ppm) and the 100 wk adenomas is given as an additional fi le: "similar 52,100, adenomas.pdf ." In this comparison, 35 genes were down-regulated relative to the kidney of control animals, 3 were Table 3 . List of differentially expressed oxidative stress genes in kidney from male rats exposed to 20 ppm (low) and 400 ppm (high) potassium bromate in drinking water for 52 wk. All comparisons were made between the specifi c treatment group and their corresponding control. Table 2 . Gene ontology (GO) analysis of differentially expressed genes (DEG) in kidneys from male rats exposed to 20 ppm (low) and 400 ppm (high) potassium bromate in drinking water for 52 wk. Results are the number of differentially expressed genes within a functional group that were either up or down regulated, with group total. Functional analyses for all groups were compiled by individual gene review. up-regulated, and 9 genes did not show the same direction of change. The majority of these downregulated genes were associated with kidney function. A common list of genes whose expression was signifi cantly altered relative to control tissue in the 52 wk high (400 ppm), the 100 wk high (400 ppm), and the 100 wk adenoma groups is given in Table 5 . In most cases, the magnitude of fold change increases with duration of exposure and/or in tumor tissue. These genes may represent potential biomarkers of bromate exposure and effect because the magnitude of their alteration is timedependent and/or a larger number of renal cells incorporate these transcript changes with continued exposure. Since tumor tissue is theoretically the product of clonal expansion of target cells, these eight genes might also aid in the development of useful tumor markers of KBrO 3 carcinogenicity. These genes were: Calb1 (Calbindin 1), Gp2 (Glycoprotein 2), Klk7 (Kallikrein 7), an EST (LOC362802), Ngfg (Nerve growth factor, gamma), Prps2 (Phosphoribosyl pyrophosphate synthetase 2), Slc12a3 (Solute carrier family 12, member 3), and Slc26a4 (Solute carrier family 26, member 4).
Gene
Control versus Low Control versus High
Kidney developmental gene response in KBrO 3 induced adenoma
The processes involved in organ development, including cell proliferation, apoptosis, cell adhesion, and differentiation, are processes that are disregulated during carcinogenesis. Therefore, a comparison was made between a previous gene expression profi le observed in rat kidney development to that of the kidney adenoma profi le from this study. Stuart et al. (2001) identifi ed fi ve groups of genes whose expression characterized stages of rat kidney development. As described in the Methods, genes were identifi ed in the current study that matched specific development groups. Figure 1A shows the average fold change of each group compared to control for low bromate, high bromate and adenoma. Early and prenatal genes, associated with cell proliferation and laying down the extracellular matrix, are up-regulated in the Table 5 . List of similar genes between 52 wk high dose potassium bromate (400 ppm), 100 wk high dose, and adenomas (n = 2) that occurred at 100 wk. This list of genes may be usable as tumor marker genes. All comparisons were made between the specifi c treatment group and their corresponding control. adenoma. Steady and adult genes, associated with energy metabolism, transport, detoxifi cation, and oxidative stress response, are down-regulated in the adenoma. This adenoma expression profi le shows the up-regulation of genes prevalent in early kidney development and down-regulation of adult stage genes. This observation is in agreement with the proliferation and de-differentiation profi les seen in classical tumor development.
52
Adenoma expression profi le resemble high dose bromate kidney
The adenoma demonstrated an expression profi le for kidney development gene groups early, prenatal, steady, and adult that was distinct from control and bromate treated kidneys. In order to determine if the adenoma profi le, as determined above, was present in part, in either the low or high KBrO 3 exposed animals, the top ten DEGs were selected from each of the four groups mentioned above. Figure 1B shows the average fold change of each group compared to control for low and high dose bromate. This fi gure illustrates that the high dose kidney, but not the low, did resemble the adenoma expression pattern with the early and prenatal phase genes being up-regulated and the steady and adult phase genes being down-regulated.
Real time PCR determination of gene expression
Quantitative Real Time rtPCR assays were conducted to verify gene expression of genes deemed biologically relevant based on pathway Figure 1A . Kidney development gene response in F344 male rats exposed to KBrO 3 in drinking water. Kidney development gene groups were defi ned in Stuart et al. (2003) and applied to our data as described in the methods section. For each group of genes, the expression was normalized to control and an average response was calculated for: 52 wk low (20 ppm) KBrO 3 , 52 wk high (400 ppm) KBrO 3 , and 100 wk KBrO 3 -induced adenomas. For each group, the average fold change normalized to control was plotted on the y-axis. Figure 1B . Gene expression pattern in F344 male rats exposed to high KBrO 3 mimics adenoma expression pattern. Kidney development gene groups were defi ned in Stuart et al. (2003) and applied to our data as described in the methods section. The differentially expressed genes in the 100 wk KBrO 3 -induced adenomas were categorized into kidney development groups. The top ten genes from each developmental group were then used in the 52 wk low (20 ppm) and high (400 ppm) KBrO 3 exposed animals. For these 50 genes, the high exposure group showed a similar expression pattern to the adenomas across kidney development groups.
Low Bromate High Bromate Adenoma
Average Normalized Expression analysis and genes that could possibly be used as biomarkers of exposure. Figure 2 shows that QRT-rtPCR results confirmed the expression patterns of the genes tested. However, differences in magnitude of change were observed, for example Aqp2 shows a -1.4 microarray fold change, but an -18.5 QRT-rtPCR fold change. This discrepancy in the magnitude of fold change between microarray data and rtPCR data has been noted in other genomics studies and may be attributable to the superior utility of the rtPCR procedure in quantifying transcript abundance (Crosby et al. 2000) . The specifi c genes selected, including target sequence are given in additional fi le: "QRT-rtPCR_ table.pdf ."
Discussion
In the DeAngelo et al. (1998) and Wolf et al. (1998) studies, male F344 rats exposed to 400 ppm KBrO 3 for 52 wk developed kidney cancer, while those exposed to 20 ppm did not. This study used the same animal kidneys from that study to determine if a difference in gene expression could be discerned between the two doses. Examining global gene expression for each dose allowed categorizing of genes into the following groups; oxidative stress, lipid metabolism, kidney function/ion transport, cellular function, and oxidoreductase function.
Oxidative stress response
Reactive oxygen species (ROS) are natural byproducts produced by the metabolism of O 2 during aerobic respiration. Oxidative stress occurs when there are increases in ROS production, and/or depressed antioxidant defense. Glutathione (GSH) is an important component of the antioxidant and detoxifi cation systems in most tissues. However, under normal cellular conditions, KBrO 3 induces oxidative DNA damage in the form of 8-oxodeoxyguanosine (8-oxodG) that is dependent on GSH and other sulfhydryls (Ballmaier and Epe, 1995; Murata et al. 2001 ). Bromate-induced oxidative DNA damage is caused by the reduction of bromate to bromine oxides and bromine radicals generated by sulfhydryls like GSH. In vivo, it has been suggested that sulfhydryls, present at the brush borders of the proximal convoluted tubule (Zager and Burkhart, 1998) , are important in the generation of bromine oxides and bromine radicals (Murata et al. 2001 ). The relative reduction of extracellular and intracellular bromate and its metabolites also affect the delivery of bromate ions to target macromolecules. Under high dose conditions, more bromate may be delivered to target cells for intracellular activation due to reduced systemic metabolism and/or antioxidant defenses (Delker et al. 2006) .
Altered gene expression associated with oxidative stress in the low dose gave only four downregulated genes Dscr1, Hspb1, Txnrd1, and Xdh. It has been reported that in oxidative stress conditions, Dscr1, Hspb1, and Txnrd1 are elevated (Ermak et al. 2004; Dunlop and Muggli, 2000; Yamawaki and Berk, 2005) , and increased levels of Xdh are associated with free radical generation (Sanhueza et al. 1992) . Dscr1 is regulated by both oxidative stress and Ca+ levels (Lin et al. 2003) , thus it may be influenced more by Ca+ ion concentration than oxidative stress. Although these genes are associated with oxidative stress, they are all down-regulated and appear to refl ect inhibition, chronic adaptation, or simply no induction of oxidative stress in animals exposed to 20 ppm KBrO 3 .
A larger involvement of proposed oxidative stress genes are seen in the high dose group with 10 DEG; 5 down-and 5 up-regulated. In the high dose response, the Dscr1 and a heat-shock gene Hspbap1, which are up-regulated in response to ROS, are down-regulated in this study. This is an unexpected response following exposure to a known producer of ROS. However, the expression observed in this experiment is that of a kidney chronically exposed to a carcinogenic dose of KBrO 3 , and may represent an adaptive gene response. Two additional down-regulated genes, Gnmt and Gsta2, are involved with GSH homeostasis and GSH conjugation, respectively.
The up-regulated oxidative stress genes include Ccng1, Cp, Gclm, and two glutathione transferases, Gstm1 and Gstp1. Studies have demonstrated that cyclin G1 (Ccng1) plays roles in G2/M arrest, damage recovery, and growth promotion after cellular stress (Kimura et al. 2001) . Cyclin G1 accomplishes this by regulating the activity of p53 (Jensen et al. 2003) . This may indicate possible oxidative stress induced DNA damage followed by increased cellular proliferation. Cp is a plasma protein that is up-regulated in response to oxidative stress and functions as a copper transporter and antioxidant. Gclm is involved in glutathione biosynthesis and is up-regulated as a defensive response to oxidative stress (Mathers et al. 2004 ).
Two glutathione S-transferases are up-regulated, Gstm1 and Gstp1. Both are involved in the conjugation of reduced GSH to a wide number of exogenous and endogenous hydrophobic electrophiles. Taken together, these data support the fi nding that KBrO 3 does produce an oxidative stress response in the kidney at high doses, however the magnitude of expression was not large, resulting in ten genes with relatively small fold-change. This may be characteristic of a kidney that has developed a resistant morphological phenotype to KBrO 3 -induced oxidative stress due to long-term chronic exposure.
Lipid metabolism
Altered lipid metabolism and lipid peroxidation have been associated with KBrO 3 exposure (Chipman et al. 1998) . Cellular fatty acids are readily oxidized by reactive oxygen species to produce lipid peroxyl radicals and lipid hydroperoxides (Rice-Evans and Burdon, 1993) . It is generally accepted that oxidative stress can lead to the oxidative degradation of lipids (Moller and Wallin, 1998) , which can disrupt normal lipid metabolism. Examination of genes associated with lipid metabolism in the low dose exposure showed 6 downregulated (Apoe, Cebpb, Chk, Cyp2e1, Cyp4a10, and Fads1 ) and 4 up-regulated genes (Abcg1, Calca, Gpd2, and Nr1d1). The down-regulated genes dealt primarily with fatty acid metabolism and lipid biosynthesis, while the up-regulated genes were associated with lipid homeostasis and metabolism. In the high dose, nine genes were down-regulated (Acaa2, Acsl3, Apoc3, Apom, Cyp2e1, Cyp4a10, Edn1, Ehhadh, Hadhsc) , and one up-regulated (Fabp5). These genes were primarily involved in fatty acid and lipid metabolism. Overall, gene expression for lipid metabolism is suppressed, with only one up-regulated gene observed in the high dose, contrary to expectations of KBrO 3 induced lipid peroxidation. This is consistent with the work of Umemura et al. (2004) which contained no evidence of lipid peroxidation by chronic treatment of rats with carcinogenic doses of KBrO 3 .
Kidney function and ion transport
The location of DEG genes involved with kidney function and ion transport within the nephron of the kidney is shown in Figure 3 . For the low dose (Fig. 3A) , of the 9 genes where specifi c locations could be identifi ed, 6 were in the proximal convo-luted tubules (PCT), 2 in the ascending loop of Henle (LH), and 1 in the distal convoluted tubules (DCT). Within the PCT, only the kidney specifi c organic anion transporter was up-regulated. For the high dose (Fig. 3B) , 7 genes were found in the PCT, 4 in the ascending LH, 5 in the DCT, and 6 genes in the collecting duct (CD). All genes in the PCT and CD were down-regulated, whereas Slc12a1 and Cldn16 were up-regulated in the ascending loop and Agtr2 was up-regulated in the DCT. When comparing the low and high fi gures, the high dose has more altered gene expression in the PCT and signifi cantly more gene involvement down-stream of the PCT with 14 altered genes compared to only 3 in the low. The localized gene expression changes depicted in this fi gure reinforce the hypothesis that as the KBrO 3 dose increases, additional cellular alterations occur in the PCT. As these changes occur, altered gene expression within and down-stream of the PCT is initiated as an attempt to maintain kidney function.
Kidney function and ion transport gene expression in the kidney from the 20 ppm exposure group showed a total of 10 genes down-and 3 up-regulated. Within the down-regulated group were genes mainly dealing with transport of water (Aqp1), sodium (Atp1a1 and Skg), potassium (Atp1a1), glucose (G6pc), and organic cations (Slc22a1). Although Aqp1 was down-regulated, no increase in water consumption was observed. In the upregulated group were genes involved in calcium homeostasis (Calca), magnesium and calcium transport (Cldn16), and organic anion transport (Slc21a4). These gene expression changes suggest a physiological response that helps maintain electrolyte balance in light of the chronic, low dose KBrO 3 exposure. Although the low concentration of KBrO 3 used in this study (20 ppm) was not carcinogenic, results from a similar study using a dose of 60 ppm in the drinking water found increased proliferation and mild degeneration of the proximal convoluted tubules (Umemura et al. 2004) . However, data collected in this paper indicate that physiological adaptation to KBrO 3 exposure is beginning to occur even at a noncarcinogenic dose.
Kidney function and ion transport gene expression in the kidney from the 400 ppm exposure group showed 20 down-and 4 up-regulated genes. Within the down-regulated group were genes involved with transport of water (Aqp2, and Aqp3), calcium (Calb1), chloride (Clcnk11 and Prkwnk4, Slc12a3, and Slc26a4), potassium (Kcnj16, Kcnq1, and Prkwnk4), sodium (Ngfg, Prkwnk4, Scnn1a, Scnn1g, Slc5a2, Slc9a3, Slc12a3, and Slc13a3) , organic ions (Slc22a5 and Slc22a8), glucose (Slc5a2 and Slc37a4), and regulation of blood pressure (End1). In the up-regulated group were Agtr2, an angiotensin II receptor; Cldn16, a magnesium and calcium transporter (also up-regulated in the low dose); Cp, an iron transporter, and Slc12a1, a sodium, potassium, chloride co-transporter. These results imply signifi cant alterations in the expression of genes involved in kidney function, and possibly decreased organ function.
In this light, when examining the DeAngelo et al. (1998) and Wolf et al. (1998) study, a dose-dependent increase in water consumption was observed starting at wk 4 and continuing through the duration of the study. Overall, it was determined that rats from the high dose (400 ppm) group drank over 30% more than controls. Taken together with the large number of down-regulated kidney function and ion transport genes from the high dose KBrO 3 exposure, these data possibly indicate a kidney in chronic renal insuffi ciency/failure. This condition occurs when the kidneys are unable to conserve water as they perform their blood fi ltering function. The amount of water conserved is controlled by antidiuretic hormone (ADH), also known as vasopressin. ADH controls kidney osmosis by inserting water pores into the collecting ducts. The water pores, Aqp2 and 3, are responsible for the fi nal adjustment of urine concentration. In the high dose animals, Aqp2 and 3 transcripts are down-regulated. This would result in fewer water pores in the collecting duct leading to increased amounts of dilute urine. With the increase in urine production, the kidney may respond to maintain ionic balance and blood volume by down-regulating the genes contributing to loss of nutrients and electrolytes and up-regulating transporter genes necessary for reabsorption, such as Slc12a1 and Cldn16.
Within the high dose PCT and CD is a downregulated gene called pendrin, or Slc26a4. Pendrin functions as a sodium-independent transporter of chloride and iodide where it is expressed in kidney, thyroid, and inner ear (Scott et al. 1999; Soleimani et al. 2001) . It should be noted that KBrO 3 , in addition to being a kidney carcinogen, is also a thyroid carcinogen, and can cause deafness (Yoshino et al. 2004) . Moreover, pendrin expression was lower in thyroid carcinomas than in normal thyroid tissue Figure 3A and 3B. Figure 3A (20 ppm) and 3B (400 ppm) show the location within the kidney nephron of specifi c genes associated with kidney function from male rats exposed to KBrO 3 for 52 wk. Genes in green and red font are down-regulated and up-regulated respectively. G: glomerulus, PCT: proximal convoluted tubules, LH: loop of Henle, DCT: distal convoluted tubules, and CD: collecting duct. (Skubis-Zegadlo et al. 2005; Kondo et al. 2003) . Pendrin transcripts examined by QT-rtPCR in this study were not altered in the low dose (20 ppm), suppressed in high dose (400 ppm), and virtually absent in kidney adenomas, mirroring the results seen in the thyroid carcinomas. Due to pendrin already being identifi ed as a biomarker in thyroid carcinogenesis, and its involvement in kidney function following KBrO 3 exposure, we propose this gene as a possible biomarker of carcinogenic KBrO 3 exposure.
Cellular function
The primary objective of this study was to determine if a discernable difference in kidney gene expression could be observed between a noncarcinogenic and carcinogenic dose of KBrO 3 . Gene ontology analysis of altered gene expression revealed an accumulation of changes in the following functionally-related categories: cancer, cell cycle, cell death, cell-to-cell signaling and interaction, cellular development, and cellular growth and proliferation. Thus, the genes that fell into these categories were placed into a general cellular functional group for analysis. Within this group were 30 down-and 11 up-regulated genes in the low KBrO 3 exposure group, and 20 downand 22 up-regulated genes in the high exposure group.
In the low KBrO 3 concentration, the majority of genes associated with cellular function were down-regulated (30 versus 11 up-regulated). Several low dose genes when down-regulated are associated with decreased cell proliferation and apoptosis (Akap12, Arhb, Cebpb, Csf 2rb, Dusp6, Epim, Gadd45a, Id2, Id3, Ig f bp3, Ig f bp6, Jun, Pim1, Rgc32, Tieg, and Veg f b) . This is countered by only one up-regulated gene Ccnd1 (Cyclin d1), which is associated with increased cell proliferation and apoptosis. From this observation, it appears that the gene expression from the low dose kidney does not support increased levels of cell proliferation similar to the BrdU findings of Umemura et al. (2004) whose no-effect level was 15 mg/L.
The gene expression in the high KBrO 3 concentration was more equally distributed with 22 downand 20 up-regulated genes. There were 10 genes shared in the cellular function category between the low and high KBrO 3 concentration. These were Cyp2e1, Dscr1, Dsipi, F3, Id2, Ig f bp1, Ms4a2, Rgc32, Ptgds, and Vipr1 . All were directionally concordant except for Ig f bp1.
In contrast to the low dose, fewer genes were associated with cell proliferation and apoptosis (Ccng1, Eno1, Hrasls3, Id2, Igfbp1, Madh7, and Nupr1) . Eno1 and Hrasls3, when down-regulated (Subramanian and Miller, 2000; Feo et al. 2000; Sers et al. 2002) , and the up-regulated genes, Nupr1, and Ccng1 promote cellular growth and proliferation. However, Id2 and Madh7 when down-regulated support decreased proliferation (Lasorella et al. 1996; Lallemand et al. 2001) . Although there are only a few genes in this group, the majority suggest increased cell proliferation and apoptosis. Stuart et al. (2001) established a benchmark expression profi le for normal kidney development. By comparing the gene expression changes in the present study to this profi le, expression changes that deviated from normal kidney were detected. In four defi ned kidney development groups, the 52 wk bromate-treated kidneys did not deviate from normal developmental patterns whereas the adenoma samples did. In these samples, the adenoma expression patterns were more characteristic of embryonic than adult kidneys. Although the bromate-treated kidneys did not show a strong expression pattern that matched the adenoma, the high dose kidney, but not the low, did resemble the adenoma expression pattern with genes prevalent in early kidney development being up-regulated and adult phase genes being down-regulated. This observation is in agreement with the proliferation and de-differentiation profi les seen in classical tumor development. Furthermore, the method of comparing developmental gene expression patterns between tumor and exposed animals could serve as a mechanism to identify biomarkers of tumor initiation.
Adenoma comparison
Conclusion
These data suggest the 400 ppm carcinogenic dose of KBrO 3 showed marked gene expression differences from the non-carcinogenic dose. These include gene expression changes in oxidative stress and kidney function/ ion transport genes. Comparison of kidney development gene expression showed that the adenoma patterns were more characteristic of embryonic than adult kidneys, and that the high dose kidney gene expression resembled an adenoma-like expression pattern. Taken together, these analyses from this study identify potential biomarkers of exposure and illuminate a possible carcinogenic mode of action for KBrO 3 . List of significantly altered oxidoreductase gene expression in kidney from male rats exposed to 20 ppm (low) and 400 ppm (high) potassium bromate in drinking water for 52 wk. 
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